Radioembolization is a targeted therapy for primary liver cancer or cancer that has spread to the liver. Types of treatable cancers include, but are not limited to:
The targeted therapy consists of millions of tiny radioactive microspheres containing yttrium-90. The radioactive microspheres are delivered directly to tumors in the liver by placing a small catheter (tube) into the artery and navigating with real-time imaging for guidance to the blood vessel(s) feeding the tumor(s). Once the blood supply is identified, the high dose radioactive microspheres are delivered directly to the tumor. Radioembolization can act as a downstaging agent allowing for curative treatment options for primary liver cancer such as radiofrequency ablation (RFA), transplant and surgery.